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E-mail address: Rob.Veale@wits.ac.za (R.B. Veale).A novel survival role of focal adhesion kinase (FAK) that involves its nuclear translocation and direct
associationwithp53hasbeendemonstrated.Hereweexamined the relationshipbetween thep53/FAK
interactionandSer46phosphorylationofp53 (p-p53Ser46) in theapoptotic regulationofhumanesoph-
ageal squamous cell carcinoma (HOSCC) cell lines, expressing eitherwild type (wt) p53 ormutant (mt)
p53-R175H. In contrast to the wt p53 cell lines, the mt p53-R175H cell line was resistant to stauro-
sporine (STS)-mediated detachment and caspase-3 activation. Furthermore, despite the resistance
of mt p53-R175H to Ser46 phosphorylation, both wt and mt HOSCC cells translocate FAK into the
nucleus and maintain the p53/FAK interaction post STS treatment. These ﬁndings provide unique
insight into how tumor cells harboring the R175Hmutantmay resist chemotherapeutic intervention.
Structured summary:
MINT-7294020: FAK (uniprotkb:Q05397) physically interacts (MI:0915) with p53 (uniprotkb:P04637) by
anti-bait coimmunoprecipitation (MI:0006)
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction matrix (ECM) activation of FAK reduces p53-dependent apoptosisInappropriate activation of survival pathways and deregulation
of cell death intermediates enables cancer cells to resist the apop-
tosis-inducing efﬁcacy of chemotherapeutic treatment. Focal adhe-
sion kinase (FAK) is a 125 kDa non-receptor protein tyrosine kinase
that is central to integrating survival signals between extracellular
and intracellular events [1,2]. Elevated expression of FAK has been
reported in various human tumors, including oral carcinoma [3]
and breast cancer [4], with elevated expression correlating with in-
creased lymph node metastasis of human esophageal squamous
cell carcinoma (HOSCC) [5]. In vitro, overexpression of FAK abro-
gates p53-mediated apoptosis, as well as p53-dependent transcrip-
tional activation of apoptotic genes [6,7]. In addition, extracellularchemical Societies. Published by E
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lar and Cell Biology, Univer-
2050, South Africa. Fax: +27[8,9], whilst FAK knockdown in combination with cisplatin treat-
ment has been shown to trigger p53-mediated apoptosis [10]. Fur-
thermore, the apoptotic events triggered by FAK deactivation are
accompanied by rapid dephosphorylation of the FAK autophospho-
rylation site, (Tyr 397 phosphorylation of FAK (pFAKTyr397)) [11].
However, it is difﬁcult to discern from these studies if cancer cells
resist p53-mediated apoptosis due to downstream effects of FAK-
dependent survival signaling, or whether FAK facilitates cell sur-
vival by direct inhibition of p53. The speciﬁc interaction between
the FERM domain of FAK and N-terminal of p53 has been proposed
to inhibit p53 activity by enhancing Mdm-2-dependent ubiquitina-
tion of p53 [10] or alternatively, inhibiting p53 transcriptional
activity by binding to the p53 transactivation domain [8,9]. Hence,
in tumor cells overexpressing FAK, manipulation of the p53/FAK
interaction may trigger p53-mediated apoptosis and thereby, en-
hance the apoptosis-inducing ability of chemotherapeutic re-
agents. Notably, the inhibitory effect of FAK on p53 has been
demonstrated to be independent of FAK catalytic activity, and reli-
ant on nuclear translocation of FAK [10].
Recently, a direct correlation between FAK overexpression and
mtp53has been demonstrated [12]. p53mutants differ in their abil-
ity to resist apoptotic stimuli. Speciﬁcally, the R175H ‘‘hot spot”mu-
tant has been shown to be apotent inhibitor of apoptosis [6,13,14]. It
has been suggested that the R175H mutation limits
the ﬂexibility of p53, thereby ‘‘locking” p53 into a more rigidlsevier B.V. All rights reserved.
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the ability to interact with other proteins [15]. Hence, the
mechanism whereby the R175H mutant resists apoptotic stimuli is
attributed to reduced transcriptional upregulation of apoptotic
intermediates, as the mutant is not resistant to ubiquitination [16].
However, as p53 activity is tightly regulated by covalent modiﬁca-
tion, the altered conformation of the p53-R175Hmutantmay confer
resistance topost-translational control. Serine46phosphorylationof
theN-terminal of p53 isbelieved tobe important for the activationof
p53 [15]. Although the exact role of Ser46 phosphorylation in apop-
tosis induction remains controversial [16,17], several studies have
demonstrated that p-p53Ser46 is a critical modiﬁcation of p53 that
irreversible commits the cell to apoptotic death [19,20].
HOSCC is a prime example of a highly malignant tumor that has
evaded the regulatory control of cell proliferation, due to deregula-
tion of pro-apoptotic proteins [21], as well as constitutive activa-
tion of survival signaling pathways [22]. Moreover, loss of the
tumor suppressor function of p53 and overexpression of FAK are
frequent events in HOSCC [5,21]. Hence, our examination of the
relationship between the p53/FAK interaction and the phosphory-
lation and mutational status of p53 in apoptotic regulation was
pertinently facilitated by HOSCC cell lines, harboring either wt or
mt p53-R175H. Even though HOSCC is highly resistant to the
anti-apoptotic ability of chemotherapeutic reagents, the data pre-
sented shows that oligonucleosomal cleavage was still inducible
by the apoptosis inducing agent staurosporine (STS), in both wt
and mt HOSCC cell lines. In contrast to the wt p53 cell lines, STS-
mediated oligonucleosomal cleavage in the mt p53-R175H cell line
was not accompanied by caspase-3 activation or FAK cleavage.
Nonetheless, despite resistance of the p53-R175H to p-p53Ser46,
both wt and mt p53 cells lines translocate FAK into the nucleus
and maintain the p53/FAK interaction post STS-mediated oligonu-
cleosomal cleavage. Hence, as the mt p53-R175H cell line was
resistant to STS-mediated detachment and p-p53Ser46, these ﬁnd-
ings provide unique insight into how tumor cells harboring the
R175H mutant may resist chemotherapeutic intervention.
2. Materials and methods
2.1. Cell lines and culture
TheWHCO1, WHCO5, WHCO6 [23] and SNO [24] human HOSCC
cell lines derived from moderately differentiated tumors were
maintained in Dulbecco’s modiﬁed eagles medium (DMEM)/Hams
F12 (3:1), supplemented with 10% fetal calf serum (FCS) and in a
humid, 37 C incubator with 5% carbon dioxide.
2.2. Oligonucleosomal cleavage analysis
Apoptosis was induced with 30 nM of STS (Sigma) for 24 h. Con-
trols were incubated in vehicle (dimethyl sulfoxide, DMSO) only.
The characteristic DNA ladder was analysed as described previ-
ously [25]. Cell death was quantiﬁed with the In Situ Cell Death
Detection Kit, POD (Roche). Standard morphological apoptotic fea-
tures were conﬁrmed in apoptotic cells, before evaluating apopto-
tic cell number. Ten random high power ﬁelds were counted for
terminal deoxynucleotidyl transferase-mediated dUTP nick end
labeling (TUNEL)-positive nuclei in each cell line. Results were ex-
pressed as the percentage of apoptotic cells in relation to the total
number of cells. Mean ± standard deviation (S.D.) was calculated
from the 10 ﬁeld views.
2.3. Cell detachment
Cells were plated at a concentration of 2  106 per 6 cm tissue
culture dish (Nunc). Following STS-treatment, detached cells werecollected, stained with 0.4% w/v Trypan Blue solution and trans-
ferred onto a haemocytometer (Fuchs-Rosenthal). The entire pro-
cess was repeated ﬁve times and the average detached cells per
total volume calculated. Attached cells were incubated in a Tryp-
sin/EDTA solution for 5 min. Trypsinized cells were collected,
transferred onto a haemocytometer and counted as described
above. STS-induced detached cells were expressed as a percentage
of total cells and mean ± S.D. was determined as above.
2.4. Statistical analyses
A standard student’s t test was used for comparative analyses.
The level of signiﬁcance was set at P < 0.05.
2.5. Immunoblot
Forty micrograms of protein per lane was resolved on 10%
sodium dodecyl sulfate polyacrylamide gel electrophoresis
(SDS–PAGE) and electro-blotted onto a nitrocellulose membrane
(Sartorius). Nonspeciﬁc binding sites on the membrane were pre-
blocked in a casein-based blocking buffer. Blots were incubated
with anti-FAK, anti-p53, anti-caspase-3 (Santa Cruz), anti-cleaved
caspase-3, anti-pp53 (Ser46) (Cell Signaling) and anti-pFAK
(Tyr397) (Millipore) antibodies respectively. Following incubation
in horseradish peroxidase (HRP)-conjugated secondary, detection
was performed with the SuperSignal West Pico Chemiluminescent
Substrate kit (Pierce, USA).
2.6. Indirect immunoﬂuorescence
STS-treated and control HOSCC cells were ﬁxed with 4% para-
formaldehyde, permeablilised with 0.25% Triton X-100 and incu-
bated with anti-FAK. Following incubation with the anti-rabbit
ﬂuoroscine isothiocyanate (FITC)-conjugated secondary antibody,
cells were viewed with a Zeiss LSM 410 confocal microscope (FITC
excitation 490, emission 525).
2.7. Co-immunoprecipitation
Cells were lysed in radioimmunoprecipitation assay (RIPA) buf-
fer containing 50 mM Tris–HCl (pH 7.5), 150 mMNaCl, 0.5% deoxy-
cholate, 0.5% Triton X-100, 0.05% SDS, 1 mM PMSF and aprotinin,
for 30 min at 4 C. Lysates containing 350 lg protein were precip-
itated with anti-p53 and 30 ll of protein G-Sepharose beads at 4 C
overnight. Samples were boiled in Laemmli buffer and then re-
solved by SDS–PAGE for immunoblot analysis.
3. Results and discussion
Recently, a novel survival role of FAK has been demonstrated
that involves its nuclear translocation and direct association with
p53 [7,10]. Furthermore, a positive correlation between FAK over-
expression and mutant p53 has been shown [12]. The ability of
mutant p53 to resist apoptotic stimuli is well established. In partic-
ular, the ‘‘hot-spot” mutant R175H has been proposed to confer
resistance to apoptosis by repressing the FAK promoter and cas-
pase-3 levels [6,14]. In view of the fact that R175H is a prevalent
mutation in most cancers, we made use of a unique model to com-
pare STS-mediated apoptosis in HOSCC cell lines expressing wt p53
(WHCO1, WHCO5 and WHCO6) with the HOSCC cell line (SNO)
harboring the mt p53-R175H (Supplementary data).
In the wt p53 HOSCC cell lines, deﬁnitive STS-induced apoptosis
was evidenced by oligonucleosomal cleavage (Fig. 1A and B) and
caspase-3 activation (Fig. 2). Although, distinct oligonucleosomal
cleavage was detected in the mt p53 cell line (Fig. 1A) no cas-
pase-3 activation was detected post STS-treatment (Fig. 2).
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percentage of TUNEL-positive nuclei was observed in the mt p53
SNO cell line post STS-treatment (Fig. 1D). The ability of STS to in-
duce caspase-3 independent oligonucleosomal cleavage has been
demonstrated in the caspase-3 null MCF-7 cell line [26]. Corre-
spondingly, under the given conditions, oligonucleosomal cleavage
was detected in the MCF-7 cell line (data not shown). As TUNEL was
performed in situ and the apoptotic DNA ladder was detected in
both adhered and detached cells (Fig. 1C), percentage detachment
was used to compare STS-mediated apoptosis between the wt and
mt p53 cell lines. Accordingly, in the mt p53-R175H cell line, the
high level of TUNEL-positive nuclei corresponded to the lowest
percentage of cell detachment (Fig. 1D). Thus, mt p53-R175H does
not protect the SNO cell line from STS-mediated oligonucleosomal
cleavage. However, in comparison to the wt cell lines, the mt p53-
R175H cell line was resistant to STS-mediated detachment and cas-
pase-3 activation.
We were able to show distinct cleavage of FAK, which corre-
sponded to caspase-3 activation and reduced expression of full-
length FAK, in the wt p53 HOSCC cell lines (Fig. 2). Conversely,
no reduced expression of FAK or cleavage was detected by immu-
noblot in the mt p53-R175H cell line. As staurosporine has been
previously shown to enhance nuclear FAK [10], we examinedFig. 1. The mt p53-R175H cell line is resistant to STS-mediated detachment. (A) STS treatm
lines. Apoptotic DNA ladder analysis in HOSCC cell lines under serum-free (SS) conditions
determined in the wt and mt p53-R175H cell lines. The highest percentage of apoptotic
evident in both the genomic DNA extracted from detached (Det) cells and attached (At) S
lowest percentage of cell detachment was observed in the mt p53 SNO cell line. MW =whether apoptotic events that initiate oligonucleosomal cleavage,
both with or without caspase-3 activation, inﬂuenced the nuclear
localisation of FAK. The nuclear translocation of FAK has been
shown to be a prerequisite for FAK-mediated inhibition of p53
[10]. Due to the disruption of the nucleus during apoptotic events
(Fig. 1A and C), analysis of the nuclear fraction became impractical.
As FAK localisation has previously been demonstrated by ﬂuores-
cence microscopy [27], STS-induced FAK nuclear translocation
was detected by immunoﬂuorescence in both the representative
wt p53 cell line (WHCO6) and mt p53-R175H cell line (SNO)
(Fig. 3). Consequently, in both wt and mt p53-R175H HOSCC cell
lines, FAK accumulates in the nucleus during cellular conditions
that initiate oligonucleosomal cleavage. Since caspase-3 activation
was not detected in the mt p53-R175H cell line, these results sug-
gest that caspase-3 dependent events do not inﬂuence stress-in-
duced FAK nuclear translocation.
As nuclear FAK has been shown to enhance the association be-
tween p53 and FAK [10], we examined whether p53 remained
associated with FAK in the wt p53 (WHCO6) and mt p53-R175H
(SNO) cell lines. In Fig. 4A we clearly show by immunoprecipitation
that FAK interacts with wt and mt p53-R175H. Hence, the R175H
mutation does not inﬂuence the p53/FAK interaction. Moreover,
during STS-mediated apoptotic events, the p53/FAK interactionent induced internucleosomal DNA fragmentation in the wt and mt p53 HOSCC cell
and treated with 30 nM STS (STS). (B) The percentage of TUNEL-positive nuclei was
nuclei was observed in the mt p53 SNO cell line. (C) The apoptotic DNA ladder was
TS-treated HOSCC cells. (D) STS induced cell detachment in the HOSCC cell lines. The
GeneRulerTM 100 bp Plus DNA ladder *P < 0.05 **P < 0.001.
Fig. 2. The mt p53-R175H cell line is resistant to FAK cleavage and caspase-3 activation. (A) The expression of FAK decreased in WHCO1, WHCO5 and WHCO6 cell lines after
treatment with STS, which was associated with the formation of the double cleavage product, in the range of 85 kDa. (B) Caspase-3 is activated with a time course
corresponding to the formation of the cleavage product in the HOSCC cell lines. Note, in the mt p53-R175H SNO cell line, neither FAK cleavage nor caspase-3 activation was
detected. A standardized loading control (L/C) was included in the ﬁrst lane of each immunoblot to allow for comparison of wt p53 cell lines. An apoptotic control (A/C)
identifying FAK cleavage and caspase-3 activation, from a wt p53 cell line was included in the ﬁrst lane of each immunoblot in the mt p53-R175H cell line.
Fig. 3. Nuclear localisation of FAK was observed post STS treatment in both wt and mt p53 cell lines, following immunoﬂuorescent detection. Scale bar = 10 lm; serum-free
conditions (SS), 30 nM STS (STS).
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Fig. 4. p53 associates with FAK independent of the R175H mutation or p-p53Ser46.
(A) p53 was detected in complex with FAK in the wt p53 WHCO6 and mt p53-
R175H SNO cells under: normal tissue culture conditions (W/C), serum-free
conditions (SS) and treated with 30 nM STS (STS). Notably, p53 was detected in
complex with cleaved FAK post STS treatment in the wt p53 WHCO6 cell line. (B)
STS-treatment results in FAK cleavage and dephosphorylation at Tyr397 in the wt
p53 WHCO6 cell line, whilst FAK was not cleaved and pFAKTyr397 remained
unchanged in mt p53 SNO cell line. p-p53Ser46 was not inﬂuenced by STS treatment
in the wt p53 WHCO6 cell line. Although p-p53Ser46 was detected in the apoptotic
control (A/C) the mt p53-R175H cell line was resistant to p-p53Ser46. Mt cont = W/C
control from mt p53-R175H cell line, APT cont = STS treated apoptotic control from
wt p53 cell line.
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is supported by the fact that p53 was detected in complex with the
cleavage product of FAK in the wt p53 WHCO6 cell line (Fig. 4A).
The generation of FAK cleavage products in the region of 85 kDa
have been reported to repress FAK phosphorylation [28] and thus
reduce FAK-dependent survival signaling. Furthermore, dephos-
phorylation of FAK has been shown to occur rapidly post STS treat-
ment [10,11]. Here we compared FAK phosphorylation in response
to STS in the wt p53 cell line (WHCO6) with the mt p53-R175H cell
line (SNO). Consistent with these studies, in the wt p53 cell line,
attenuation of FAK phosphorylation corresponded to FAK cleavage
and caspase-3 activation (Figs. 2 and 4B). In contrast, in the detach-
ment-resistant mt p53-R175H cell line, STS induced oligonucleos-
omal cleavage was not accompanied by FAK cleavage or Tyr397
dephosphorylation. Hence, the repressive effect that mt p53-
R175H has been established to have on the FAK promoter [6]
may be responsible for the constitutive phosphorylation of FAK ob-
served in the SNO cell line and, subsequently, protect cancer cells
from detachment-induced apoptosis.
Although Ser46 phosphorylation site of p53 has been reported
to enhance p53-mediated transcriptional activation of apoptotic
genes [16–18], p-p53Ser46 has been demonstrated to be dispens-
able for p53-mediated apoptosis [19,20]. Consistent with the lat-
ter of these studies, no substantial change in p-p53Ser46 was
evident following FAK cleavage in the wt p53-R175H cell line
(Fig. 4B). However, in the SNO cell line harboring p53-R175H,
p-p53Ser46 was not detected by immunoblot, even in the pres-
ence of oligonucleosomal cleavage (Fig. 4B). Consequently, asSer46 phosphorylation of p53 was not detected in the SNO cell
line and we observed the p53/FAK interaction in both wt and
mt p53 cell lines (Fig. 4A), p-p53Ser46 is not required to disrupt
the p53/FAK association.
Esophageal carcinoma is a cancer that is particularly resistant to
chemotherapeutic treatment due to loss of tumor suppressor func-
tion of p53 and constitutive activation of survival signaling [21,22].
Here we demonstrate that, in the detachment-resistant mt
p53-R175H SNO cell line, FAK remained phosphorylated at
Tyr397 under the same conditions that three wt p53 cell lines dis-
played FAK cleavage and caspase-3 activation. As a direct correla-
tion between overexpression of FAK and mutant p53 has been
demonstrated in breast cancer [12], the inhibition of FAK phos-
phorylation in apoptotic-resistant esophageal tumors harboring
the p53-R175Hmutant may be a viable therapeutic option. In addi-
tion, although the mt p53-R175H cell line was not resistant to the
p53/FAK association, the p53-R175H mt was not susceptible to
Ser46 phosphorylation. The absence of Ser46 phosphorylation en-
ables oral squamous cell carcinoma to resist wt p53 gene delivery
[29]. Furthermore, Ser46 phosphorylation of p53 has been shown
to repress oncogene-induced immortalization [20]. Hence, further
studies that characterise the post-translational modiﬁcation of
mt p53-R175H and the other ‘‘hot-spot” mutants may enhance
the understanding of the mechanism whereby mt p53 enables
tumors to resist chemotherapeutic treatment.
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